New start-up companies are constantly commercialising new technologies and services. Genomics is ripe for investment right now.

New Open Source Platform Targets Precision Medicine

Johns Hopkins, Harvard, and Sanger Institute begin Arvados pilot projects. Curoverse today announced their new open source platform Arvados is available for trial through a public beta. The software provides an infrastructure to manage, process, and share genomic and biomedical data in precision medicine development. ÔÇťArvados enables users to do science and medicine bioinformatics that […]